Medical Marijuana Inc.

Name

Medical Marijuana Inc.

Legal name

Medical Marijuana, Inc.

Website

https://medicalmarijuanainc.com

Company type

Public

Founded year

2003

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Cannabis Nutraceuticals

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

CBD/Hemp Wellness & Supplements Retail (CRANAHAC)

akta.pro secondary industry

Medical Cannabis Dispensaries (CRANAFAB)

Keywords

• Hemp CBD products
• Cannabinoid nutraceuticals
• Network marketing CBD
• Medical cannabis distribution
• Botanical drug development

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Consumer CBD Products: Sale of hemp-derived CBD products including oils, tinctures, capsules, topicals, and edibles through e-commerce and network marketing channels. 2020 revenue of $46.9M with margins over 75%.
2. Network Marketing (Kannaway): Revenue generated through Kannaway subsidiary's network marketing model where independent distributors earn commissions on product sales. Kannaway achieved largest revenue month in company history for Japan Division in June 2022.
3. Pharmaceutical Investment Companies: Investment returns from pharmaceutical subsidiaries and partners including AXIM Biotechnologies and Neuropathix focused on cannabinoid-based clinical research and botanical drug development.
4. International Distribution: Revenue from distribution across 40+ countries with health authority approvals in Mexico and Brazil. HempMeds Brasil subsidiary generates revenue through CBD product sales in Brazilian market.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Medical Marijuana, Inc. is a publicly traded holding company that sells hemp-derived, non-psychoactive cannabinoid (CBD) products — including CBD oils, tinctures, capsules, topicals, and edibles — through three business units: the Kannaway network-marketing subsidiary, the HempMeds consumer brand with international distribution, and pharmaceutical investment partners (AXIM Biotechnologies, Neuropathix) focused on cannabinoid-based clinical research and botanical drug development.

Product overview

Medical Marijuana, Inc. is a cannabis company operating three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway (network marketing/direct sales) and HempMeds; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by pharmaceutical investment companies including AXIM Biotechnologies and Neuropathix. The company's flagship product is Real Scientific Hemp Oil (RSHO), while subsidiaries like HempMeds Brasil and HM Pharma have received health authority approvals in Brazil and Mexico. Products span CBD oil concentrates, tinctures, capsules, topicals, and full spectrum concentrations, distributed across 40+ countries with 100+ SKUs across 12 brands. The company achieved $46.9M revenue in 2020 with margins over 75%.

Differentiator

Problem solved

Functional benefit

Brands

• Kannaway®: Direct sales and network marketing subsidiary offering CBD products
• HempMeds®
• HempMeds® Brasil
• Real Scientific Hemp Oil (RSHO)

Quantifiable outcome

• 2020 revenue of $46.9M with gross margins over 75%
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered major and core.

• KZ1 Network Marketing CompanymajorStrategic or Co-development Partner · 1 August 2023Medical Marijuana, Inc.'s Kannaway division completed the acquisition of KZ1 Network Marketing Company, expanding its network marketing distributor base and market presence.
• MFINITY Global LLCmajorStrategic or Co-development Partner · 4 October 2022Medical Marijuana, Inc. entered into an asset purchase agreement with MFINITY Global LLC and appointed the MFINITY President as President of Kannaway. This partnership strengthened Kannaway's network marketing leadership with experienced executives from the network marketing industry.
• HM PharmamajorStrategic or Co-development Partner · 11 August 2022Medical Marijuana, Inc. subsidiary HM Pharma submitted CBD product dossier and received sanitary registration in Brazil, enabling expanded pharmaceutical-grade CBD product distribution in the Brazilian market.
• AXIM® Biotechnologies, InccoreStrategic or Co-development PartnerMedical Marijuana, Inc. maintains pharmaceutical investment in AXIM Biotechnologies, a company focused on cannabinoid-based clinical research and botanical drug development. AXIM represents the company's entry into the pharmaceutical sector for development of cannabis-derived medicines.
• NeuropathixcoreStrategic or Co-development PartnerMedical Marijuana, Inc. has pharmaceutical investment partnerships with Neuropathix focused on cannabinoid research and drug development, expanding the company's footprint in clinical research and botanical pharmaceutical development.
• HempMeds® BrasilcoreChannel Partner/ Reseller/ DistributorSubsidiary of Medical Marijuana, Inc. focused on distributing CBD products in Brazil. Has received sanitary registration from Brazilian health authorities and launched new full spectrum concentrations (3,000mg to 6,000mg) in jars of 30 and 60mL.
• Kannaway®coreChannel Partner/ Reseller/ DistributorPrimary subsidiary of Medical Marijuana, Inc. operating as a direct sales and network marketing company offering CBD products. Achieved largest revenue month in company history for Japan Division in June 2022. Expanded leadership team with industry veterans as Executive Vice President and VP of Information Technology.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Elixinol Wellness: CBD wellness brand offering hemp-derived CBD products globally, including in markets with restrictive cannabis regulations. Direct peer in international CBD distribution and premium wellness positioning.
• cbdMD: Publicly traded CBD brand (YCBD) offering CBD oils, topicals, gummies, and sleep/relaxation products direct-to-consumer. Comparable to MJNA in product mix, DTC model, and Triple Lab Tested-style quality positioning.
• CV Sciences: Publicly traded company (CVSI) producing hemp-derived CBD products under the PlusCBD Oil brand for the health and wellness market. Direct competitor to MJNA's CBD oil, capsule, and topical product lines.
• Charlotte's Web Holdings: Publicly traded CBD wellness company offering hemp-derived CBD products across tinctures, capsules, topicals, and pet products. Directly comparable to MJNA's HempMeds and Kannaway brands in the CBD consumer category.
• HempFusion Wellness: Publicly traded hemp-derived CBD wellness company offering tinctures, topicals, and capsules distributed through retail and DTC channels. Comparable in product mix, regulatory positioning, and distribution model.

Broad incumbents

• Canopy Growth: Large multi-national cannabis company with CBD and medical cannabis operations across North America and international markets. Provides scale and capital benchmarking for MJNA's aspirations in Latin American medical cannabis.
• Curaleaf Holdings: Multi-state cannabis operator with CBD wellness product lines and medical dispensary operations. Comparable to MJNA's medical cannabis dispensary exposure in select US/international markets.
• Tilray Brands: Global cannabis and consumer packaged goods company with hemp-derived CBD wellness products and international medical cannabis distribution. Comparable in international distribution footprint and CBD product breadth.

Emerging players

• AXIM Biotechnologies: Cannabinoid-based pharmaceutical research and drug development company in which MJNA holds an investment. Comparable through MJNA's equity exposure and overlapping focus on cannabinoid-derived therapeutics.

Regional players

• Neptune Wellness Solutions: Cannabis and CBD wellness company focused on extraction, product development, and brand distribution primarily in North America. Comparable as a publicly traded CBD-focused operator with similar product categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/MJNA_INC
• YouTubeyoutube.com/channel/UCfJ-VQXURYGyamdm-Lpi2Bg
• Facebookfacebook.com/mjnainc
• LinkedInlinkedin.com/company/medical-marijuana-inc-
• Instagraminstagram.com/mjna_inc
• Pinterestpinterest.com.mx/medicalmarijuanainc/_created

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries7 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Marijuana Inc.